Status:
COMPLETED
Pre TAVI Membranous Septum Measurement Predicts High Grade Iatrioventricular Conduction Disorders in Patients With Specific Pacemaker Implanted After TAVI. The STIM TAVI-MS Study
Lead Sponsor:
Association de Recherche en Cardiologie des Alpes
Conditions:
Conduction Disturbance
Trans Aortic Valve Implantation (TAVI)
Eligibility:
All Genders
18+ years
Brief Summary
Conduction disturbances are a major complication of TAVI. There is no predictor of post-TAVI conduction disorder. The study of the membranous septum on the pre-TAVI scanner and the valve implantation ...
Detailed Description
After being developed for the treatment of aortic stenosis in inoperable patients, trans aortic valve implantation (TAVI) techniques and devices have gradually improved, and its use can now be conside...
Eligibility Criteria
Inclusion
- 18 years old
- Patients included in the STIM TAVI study with full follow-up (not excluded from STIM TAVI for lack of data)
- Patients who did not object to the use of CT and angiography data
Exclusion
- Oral opposition to participate
Key Trial Info
Start Date :
June 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 26 2021
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT04906837
Start Date
June 20 2020
End Date
February 26 2021
Last Update
May 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Annecy Genevois
Annecy, France, 74370